Resveratrol promotes HSV-2 replication by increasing histone acetylation and activating NF-κB.

[1]  S. Chanda,et al.  SNW1, a Novel Transcriptional Regulator of the NF-κB Pathway , 2018, Molecular and Cellular Biology.

[2]  G. Freeman,et al.  Arming an Oncolytic Herpes Simplex Virus Type 1 with a Single-chain Fragment Variable Antibody against PD-1 for Experimental Glioblastoma Therapy , 2018, Clinical Cancer Research.

[3]  N. Mukaida,et al.  Resveratrol stimulation induces interleukin‐8 gene transcription via NF‐&kgr;B , 2018, Pharmacological research.

[4]  Imran M. Shaikh,et al.  Toxicity and Efficacy of a Novel GADD34-expressing Oncolytic HSV-1 for the Treatment of Experimental Glioblastoma , 2018, Clinical Cancer Research.

[5]  W. Shao,et al.  Bromodomain-containing protein 4–independent transcriptional activation by autoimmune regulator (AIRE) and NF-κB , 2018, The Journal of Biological Chemistry.

[6]  Eui Tae Kim,et al.  Time-resolved Global and Chromatin Proteomics during Herpes Simplex Virus Type 1 (HSV-1) Infection* , 2017, Molecular & Cellular Proteomics.

[7]  Erguang Li,et al.  An Epigenetic Compound Library Screen Identifies BET Inhibitors That Promote HSV-1 and -2 Replication by Bridging P-TEFb to Viral Gene Promoters through BRD4 , 2016, PLoS pathogens.

[8]  T. Kristie.  Dynamic modulation of HSV chromatin drives initiation of infection and provides targets for epigenetic therapies. , 2015, Virology.

[9]  Peter Vickerman,et al.  Global Estimates of Prevalent and Incident Herpes Simplex Virus Type 2 Infections in 2012 , 2015, PloS one.

[10]  D. Hazuda,et al.  Activation of HIV Transcription with Short-Course Vorinostat in HIV-Infected Patients on Suppressive Antiretroviral Therapy , 2014, PLoS pathogens.

[11]  M. Hagiwara,et al.  CDK9 inhibitor FIT-039 prevents replication of multiple DNA viruses. , 2014, The Journal of clinical investigation.

[12]  M. Caligiuri,et al.  Bortezomib-Induced Unfolded Protein Response Increases Oncolytic HSV-1 Replication Resulting in Synergistic Antitumor Effects , 2014, Clinical Cancer Research.

[13]  R. Sandri-Goldin,et al.  Inhibition of cdk9 during Herpes Simplex Virus 1 Infection Impedes Viral Transcription , 2013, PloS one.

[14]  C. Busch,et al.  Correction: Resveratrol as a Pan-HDAC Inhibitor Alters the Acetylation Status of Jistone Proteins in Human-Derived Hepatoblastoma Cells , 2013, PLoS ONE.

[15]  C. Busch,et al.  Resveratrol as a Pan-HDAC Inhibitor Alters the Acetylation Status of Jistone Proteins in Human-Derived Hepatoblastoma Cells , 2013, PloS one.

[16]  Erguang Li,et al.  Houttuynia cordata blocks HSV infection through inhibition of NF-κB activation , 2011, Antiviral Research.

[17]  J. Pezzuto,et al.  What Is New for an Old Molecule? Systematic Review and Recommendations on the Use of Resveratrol , 2011, PloS one.

[18]  Craig S. Miller,et al.  Histone deacetylase inhibitors induce reactivation of herpes simplex virus type 1 in a latency-associated transcript-independent manner in neuronal cells , 2005, Journal of NeuroVirology.

[19]  Yu Liang,et al.  Inhibition of the histone demethylase LSD1 blocks α-herpesvirus lytic replication and reactivation from latency , 2009, Nature Medicine.

[20]  D. Knipe,et al.  Herpes Simplex Virus ICP0 Promotes both Histone Removal and Acetylation on Viral DNA during Lytic Infection , 2008, Journal of Virology.

[21]  B. Roizman,et al.  Role of cdk9 in the Optimization of Expression of the Genes Regulated by ICP22 of Herpes Simplex Virus 1 , 2008, Journal of Virology.

[22]  R. Orlando,et al.  Curcumin and resveratrol inhibit nuclear factor-kappaB-mediated cytokine expression in adipocytes , 2008, Nutrition & metabolism.

[23]  D. Knipe,et al.  Chromatin control of herpes simplex virus lytic and latent infection , 2008, Nature Reviews Microbiology.

[24]  N. Fraser,et al.  Temporal Association of the Herpes Simplex Virus Genome with Histone Proteins during a Lytic Infection , 2007, Journal of Virology.

[25]  L. Kopelovich,et al.  Resveratrol: a review of preclinical studies for human cancer prevention. , 2007, Toxicology and applied pharmacology.

[26]  Joseph A. Baur,et al.  Therapeutic potential of resveratrol: the in vivo evidence , 2006, Nature Reviews Drug Discovery.

[27]  B. Marinari,et al.  Herpes Simplex Virus Disrupts NF-κB Regulation by Blocking Its Recruitment on the IκBα Promoter and Directing the Factor on Viral Genes* , 2006, Journal of Biological Chemistry.

[28]  S. Berger,et al.  During Lytic Infection Herpes Simplex Virus Type 1 Is Associated with Histones Bearing Modifications That Correlate with Active Transcription , 2004, Journal of Virology.

[29]  F. J. Herrera,et al.  VP16-Dependent Association of Chromatin-Modifying Coactivators and Underrepresentation of Histones at Immediate-Early Gene Promoters during Herpes Simplex Virus Infection , 2004, Journal of Virology.

[30]  B. Roizman,et al.  Herpes Simplex Virus 1 Gene Expression Is Accelerated by Inhibitors of Histone Deacetylases in Rabbit Skin Cells Infected with a Mutant Carrying a cDNA Copy of the Infected-Cell Protein No. 0 , 2003, Journal of Virology.

[31]  S. Pervaiz.  Resveratrol: from grapevines to mammalian biology , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[32]  C. Amici,et al.  NEW EMBO MEMBER’S REVIEW: NF-κB and virus infection: who controls whom , 2003 .

[33]  J. Marier,et al.  Metabolism and Disposition of Resveratrol in Rats: Extent of Absorption, Glucuronidation, and Enterohepatic Recirculation Evidenced by a Linked-Rat Model , 2002, Journal of Pharmacology and Experimental Therapeutics.

[34]  C. Amici,et al.  Activation of IκB Kinase by Herpes Simplex Virus Type 1 , 2001, The Journal of Biological Chemistry.

[35]  C. Amici,et al.  Activation of I kappa b kinase by herpes simplex virus type 1. A novel target for anti-herpetic therapy. , 2001, The Journal of biological chemistry.

[36]  B. Peterlin,et al.  NF-κB Binds P-TEFb to Stimulate Transcriptional Elongation by RNA Polymerase II , 2001 .

[37]  S. Manna,et al.  Resveratrol Suppresses TNF-Induced Activation of Nuclear Transcription Factors NF-κB, Activator Protein-1, and Apoptosis: Potential Role of Reactive Oxygen Intermediates and Lipid Peroxidation1 , 2000, The Journal of Immunology.

[38]  J. Zeh,et al.  Reactivation of genital herpes simplex virus type 2 infection in asymptomatic seropositive persons. , 2000, The New England journal of medicine.

[39]  W. Miller,et al.  Herpes Simplex Virus Type 1 Induction of Persistent NF-κB Nuclear Translocation Increases the Efficiency of Virus Replication , 1998 .

[40]  J. Zeh,et al.  Virologic characteristics of subclinical and symptomatic genital herpes infections. , 1995, The New England journal of medicine.

[41]  T. Mosmann.  Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. , 1983, Journal of immunological methods.

[42]  E. Kieff,et al.  Characterization of herpes simplex virus strains differing in their effects on social behaviour of infected cells. , 1968, The Journal of general virology.